Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silence Therapeutics (SLN) Prepaid Assets (2018 - 2025)

Silence Therapeutics' Prepaid Assets history spans 8 years, with the latest figure at $11.5 million for Q4 2025.

  • On a quarterly basis, Prepaid Assets fell 21.32% to $11.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $11.5 million, a 21.32% decrease, with the full-year FY2025 number at $11.5 million, down 21.32% from a year prior.
  • Prepaid Assets hit $11.5 million in Q4 2025 for Silence Therapeutics, up from $9.3 million in the prior quarter.
  • Over the last five years, Prepaid Assets for SLN hit a ceiling of $16.4 million in Q1 2025 and a floor of $4.0 million in Q3 2021.
  • Historically, Prepaid Assets has averaged $11.0 million across 5 years, with a median of $11.3 million in 2023.
  • Biggest five-year swings in Prepaid Assets: surged 206.81% in 2022 and later plummeted 40.43% in 2025.
  • Tracing SLN's Prepaid Assets over 5 years: stood at $5.8 million in 2021, then surged by 65.58% to $9.6 million in 2022, then rose by 17.88% to $11.3 million in 2023, then rose by 29.34% to $14.7 million in 2024, then fell by 21.32% to $11.5 million in 2025.
  • Business Quant data shows Prepaid Assets for SLN at $11.5 million in Q4 2025, $9.3 million in Q3 2025, and $14.4 million in Q2 2025.